Bank of New York Mellon
STML

Bank of New York Mellon’s Stemline Therapeutics, Inc. STML Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-184,334
Closed -$892K 4196
2020
Q1
$892K Sell
184,334
-746
-0.4% -$3.61K ﹤0.01% 3064
2019
Q4
$1.97M Buy
185,080
+2,272
+1% +$24.1K ﹤0.01% 2825
2019
Q3
$1.9M Buy
182,808
+20,760
+13% +$216K ﹤0.01% 2778
2019
Q2
$2.48M Sell
162,048
-9,154
-5% -$140K ﹤0.01% 2686
2019
Q1
$2.2M Buy
171,202
+36,446
+27% +$469K ﹤0.01% 2730
2018
Q4
$1.28M Buy
134,756
+28,198
+26% +$268K ﹤0.01% 2965
2018
Q3
$1.77M Buy
106,558
+2,752
+3% +$45.7K ﹤0.01% 2913
2018
Q2
$1.67M Sell
103,806
-9,772
-9% -$157K ﹤0.01% 2961
2018
Q1
$1.74M Buy
113,578
+12,765
+13% +$195K ﹤0.01% 2883
2017
Q4
$1.57M Buy
100,813
+18,899
+23% +$295K ﹤0.01% 2978
2017
Q3
$909K Sell
81,914
-4,282
-5% -$47.5K ﹤0.01% 3278
2017
Q2
$794K Sell
86,196
-895
-1% -$8.24K ﹤0.01% 3383
2017
Q1
$745K Buy
87,091
+23,077
+36% +$197K ﹤0.01% 3398
2016
Q4
$685K Buy
64,014
+14,281
+29% +$153K ﹤0.01% 3447
2016
Q3
$539K Sell
49,733
-2,375
-5% -$25.7K ﹤0.01% 3500
2016
Q2
$353K Sell
52,108
-2,438
-4% -$16.5K ﹤0.01% 3681
2016
Q1
$254K Buy
54,546
+315
+0.6% +$1.47K ﹤0.01% 3703
2015
Q4
$343K Sell
54,231
-285
-0.5% -$1.8K ﹤0.01% 3656
2015
Q3
$482K Sell
54,516
-19,904
-27% -$176K ﹤0.01% 3567
2015
Q2
$876K Sell
74,420
-4,843
-6% -$57K ﹤0.01% 3411
2015
Q1
$1.15M Buy
79,263
+24,662
+45% +$357K ﹤0.01% 3226
2014
Q4
$932K Buy
54,601
+5,599
+11% +$95.6K ﹤0.01% 3347
2014
Q3
$610K Buy
49,002
+170
+0.3% +$2.12K ﹤0.01% 3549
2014
Q2
$717K Buy
48,832
+8,521
+21% +$125K ﹤0.01% 3484
2014
Q1
$820K Sell
40,311
-758
-2% -$15.4K ﹤0.01% 3377
2013
Q4
$805K Sell
41,069
-1,649
-4% -$32.3K ﹤0.01% 3397
2013
Q3
$1.93M Buy
42,718
+7,232
+20% +$327K ﹤0.01% 2866
2013
Q2
$846K Buy
+35,486
New +$846K ﹤0.01% 3272